Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$4.02 - $10.43 $736,166 - $1.91 Million
-183,126 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$8.43 - $20.9 $56,641 - $140,427
-6,719 Reduced 3.54%
183,126 $1.67 Million
Q4 2021

Feb 07, 2022

SELL
$19.26 - $30.08 $1.21 Million - $1.89 Million
-62,834 Reduced 24.87%
189,845 $3.97 Million
Q3 2021

Nov 04, 2021

SELL
$24.86 - $35.02 $353,310 - $497,704
-14,212 Reduced 5.33%
252,679 $6.46 Million
Q2 2021

Aug 06, 2021

SELL
$22.3 - $36.02 $544,766 - $879,932
-24,429 Reduced 8.39%
266,891 $9.33 Million
Q1 2021

May 06, 2021

BUY
$26.38 - $51.15 $5.22 Million - $10.1 Million
197,695 Added 211.16%
291,320 $9.7 Million
Q4 2020

Feb 09, 2021

SELL
$10.5 - $28.5 $157,993 - $428,839
-15,047 Reduced 13.85%
93,625 $2.43 Million
Q3 2020

Nov 10, 2020

BUY
$3.61 - $9.87 $26,223 - $71,695
7,264 Added 7.16%
108,672 $1.07 Million
Q2 2020

Aug 06, 2020

BUY
$2.65 - $4.03 $75,095 - $114,202
28,338 Added 38.78%
101,408 $350,000
Q1 2020

May 11, 2020

BUY
$2.36 - $5.26 $7,120 - $15,869
3,017 Added 4.31%
73,070 $224,000
Q4 2019

Feb 05, 2020

BUY
$4.6 - $5.57 $127,847 - $154,807
27,793 Added 65.77%
70,053 $368,000
Q3 2019

Nov 12, 2019

BUY
$4.99 - $6.16 $4,421 - $5,457
886 Added 2.14%
42,260 $218,000
Q2 2019

Aug 08, 2019

BUY
$5.92 - $7.41 $65,528 - $82,021
11,069 Added 36.53%
41,374 $250,000
Q1 2019

Apr 26, 2019

BUY
$6.8 - $7.4 $4,984 - $5,424
733 Added 2.48%
30,305 $219,000
Q4 2018

Feb 08, 2019

BUY
$3.99 - $7.82 $117,992 - $231,253
29,572 New
29,572 $216,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $301M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.